[DGTR tracker](https://indusdesk.com/dgtr/tracker/)

# DGTR opens anti-dumping investigation into methyl chloroformate from China

https://indusdesk.com/dgtr/tracker/opens-anti-dumping-investigation-into-methyl-chloroformate-271107/

The application was filed by M/s. Paushak Limited, M/s Superform Chemistries Limited and UPL Limited, which state that they account for 100% of Indian production. MCF is described as a colorless, volatile liquid used as an intermediate in the pharmaceutical and agrochemical industries.

Case No. AD(OI) - 08/2026 · Initiation · March 19, 2026

IndusDesk · March 19, 2026

The Directorate General of Trade Remedies has initiated an anti-dumping investigation, by notification dated March 19, 2026 (Case No. AD(OI) - 08/2026), concerning imports of Methyl Chloroformate (MCF) in any concentration originating in or exported from China.

The application was filed by M/s. Paushak Limited, M/s Superform Chemistries Limited and UPL Limited, which state that they account for 100% of Indian production. MCF is described as a colorless, volatile liquid used as an intermediate in the pharmaceutical and agrochemical industries. It has no dedicated HS code and is reported to be imported in particular under sub-heading 2915 12 90, and also under 2915 13 00, 2915 90 99 and 2933 39 90.

The period of investigation is October 1, 2024 to September 30, 2025, and the injury period covers the three financial years from April 1, 2022 to March 31, 2025 and the period of investigation. The applicants ask that China be treated as a non-market economy, and normal value was constructed from their own cost of production. The Authority finds prima facie evidence of a dumping margin above de minimis, rising import volumes, price suppression and depression, and an adverse effect on profitability.

Interested parties must register on the SETU portal and file questionnaire responses within 37 days from circulation of the non-confidential version of the application. Comments on the product scope and PCN methodology are due within 15 days, running concurrently. The Authority will determine the existence, degree and effect of dumping and recommend any duty needed to remove injury.

**Measure**: Anti-dumping

**Stage**: Initiation

**Case number**: Case No. AD(OI) - 08/2026

**File number**: F. No. 6/08/2026 -DGTR

**Dated**: March 19, 2026

**Published in the Gazette**: March 19, 2026

**Put online**: March 21, 2026

**Gazette ID**: CG-DL-E-21032026-271107

**Product**: Methyl Chloroformate (MCF) in any concentration

**What it covers**: Methyl Chloroformate (MCF) in any concentration, an organic chemical compound that is a colorless, volatile liquid widely used as an intermediate, with its usage found in the pharmaceutical and agrochemical industries. The applicants have not proposed a product control number (PCN) methodology, and the customs classification is indicative only and not binding on the scope.

**Customs codes**: 2915 12 90, 2915 13 00, 2915 90 99, 2933 39 90

**Countries**: China

**Applicant**: M/s. Paushak Limited, M/s Superform Chemistries Limited and UPL Limited

**Period of investigation**: 1st October 2024 to 30th September 2025 (12 months)

**Injury period**: 1st April 2022 to 31st March 2023, 1st April 2023 to 31st March 2024, 1st April 2024 to 31st March 2025 and the period of investigation

**Findings**:

- The applicants state that they account for 100% of the total production of the subject goods in India; the Authority states that they constitute the domestic industry under Rule 2(b) and that the application satisfies the standing requirement under Rule 5(3).

- The applicants claim China should be treated as a non-market economy; normal value was constructed on the applicants' cost of production, adjusted for selling, general and administrative expenses, with reasonable profit.

- A comparison of normal value and export price at ex-factory level prima facie shows a dumping margin above the de-minimis level.

- The applicants provided prima facie evidence that subject import volumes increased during the injury period, with price suppression, price depression and an adverse impact on profitability.

- The Authority prima facie finds sufficient evidence of dumping, injury and causal link to justify initiation under Rule 5.

**Recommendation**: The Authority initiates an anti-dumping investigation under Section 9A of the Act read with Rule 5 to determine the existence, degree and effect of dumping and to recommend an appropriate amount of anti-dumping duty adequate to remove injury.

**Time limits**:

- Comments on the scope of the product under consideration and proposed PCN methodology: within 15 days of circulation of the receipt of intimation of initiation of the investigation, running concurrently with the time limit for submissions

- Questionnaire responses and other submissions, confidential and non-confidential versions, on the SETU portal (SETU Case ID AD/OI/009/2026): within 37 days from the date on which the non-confidential version of the application is circulated by the Authority or transmitted to the diplomatic representative of the exporting country

- Requests for extension of time: at least one day before the original deadline

- Comments on issues of confidentiality: within 7 days from the date of circulation of the non-confidential version of the documents

[The notification](https://files.indusdesk.com/dgtr/cases/ad-oi-08-2026/initiation-2026-03-19.pdf) (PDF, 841 KB)

Gazette of India, [CG-DL-E-21032026-271107](https://egazette.gov.in/WriteReadData/2026/271107.pdf), published March 19, 2026.

Checked against the official copy on October 20, 2026.

- [DGTR guide](https://indusdesk.com/dgtr/)

- [All DGTR notifications](https://indusdesk.com/dgtr/tracker/)
